Literature DB >> 29434007

MSCs-cells with many sides.

Katarina Le Blanc1, Lindsay C Davies2.   

Abstract

The field of mesenchymal stromal cell (MSC) biology and clinical cellular therapy has grown exponentially over the last few decades. With discovery of multiple tissue specific sources of stromal cells, invariably being termed MSCs, and their increasing clinical application, there is a need to further delineate the true definition of a mesenchymal stromal cell and to recognise the inherit differences between cell sources; both their potential and limitations. In this review, we discuss the importance of considering every stromal cell source as an independent entity and the need to critically evaluate and appreciate the true phenotype of these cells and their safety when considering their use in novel cell therapies.
Copyright © 2018. Published by Elsevier Inc.

Mesh:

Year:  2018        PMID: 29434007     DOI: 10.1016/j.jcyt.2018.01.009

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  36 in total

Review 1.  Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy.

Authors:  Shen Cheng; Susheel Kumar Nethi; Sneha Rathi; Buddhadev Layek; Swayam Prabha
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

2.  Adipose tissue-derived mesenchymal stem cells rescue the function of islets transplanted in sub-therapeutic numbers via their angiogenic properties.

Authors:  Gang Ren; Melika Rezaee; Mehdi Razavi; Ahmed Taysir; Jing Wang; Avnesh S Thakor
Journal:  Cell Tissue Res       Date:  2019-02-01       Impact factor: 5.249

3.  The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.

Authors:  I-I Kuan; Chi-Chiu Lee; Chien-Hsu Chen; Jean Lu; Yuan-Sung Kuo; Han-Chung Wu
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

4.  Impact of donor characteristics on the quality of bone marrow as a source of mesenchymal stromal cells.

Authors:  Emilia Barreto-Durán; Claudia Camila Mejía-Cruz; Efrain Leal-García; Rafael Pérez-Núñez; Viviana Marcela Rodríguez-Pardo
Journal:  Am J Stem Cells       Date:  2018-12-01

5.  Phenotypic and Functional Characterizations of Mesenchymal Stem/Stromal Cells Isolated From Human Cranial Bone Marrow.

Authors:  Kaichuang Yang; Ruijie Lu; Jianan Lu; Shucai Fan; Qiang Zhang; Zijian Lou; Yuyuan Ma; Gang Lu; Ruolang Pan; Jianmin Zhang
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

Review 6.  Mesenchymal Stromal Cell Therapy in Spinal Cord Injury: Mechanisms and Prospects.

Authors:  Ji-Le Xie; Xing-Ran Wang; Mei-Mei Li; Zi-Han Tao; Wen-Wen Teng
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

7.  Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome.

Authors:  Raghavan Chinnadurai; Matthew H Forsberg; John A Kink; Peiman Hematti; Christian M Capitini
Journal:  Curr Stem Cell Rep       Date:  2020-08-08

8.  The Novel miRNA N-72 Regulates EGF-Induced Migration of Human Amnion Mesenchymal Stem Cells by Targeting MMP2.

Authors:  Ying Li; Dianbao Zhang; Meng Chen; Rui Wang; Tao Zhang; Feng Zhao; Xuewen Lin; Xining Pang
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

9.  Stromal Heterogeneity in the Human Proliferative Endometrium-A Single-Cell RNA Sequencing Study.

Authors:  Suzanna Queckbörner; Carolina von Grothusen; Nageswara Rao Boggavarapu; Roy Mathew Francis; Lindsay C Davies; Kristina Gemzell-Danielsson
Journal:  J Pers Med       Date:  2021-05-22

10.  Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.

Authors:  Lingling Tang; Yingan Jiang; Mengfei Zhu; Lijun Chen; Xiaoyang Zhou; Chenliang Zhou; Peng Ye; Xiaobei Chen; Baohong Wang; Zhenyu Xu; Qiang Zhang; Xiaowei Xu; Hainv Gao; Xiaojun Wu; Dong Li; Wanli Jiang; Jingjing Qu; Charlie Xiang; Lanjuan Li
Journal:  Front Med       Date:  2020-08-06       Impact factor: 9.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.